Phase 3 efficacy and safety study of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity

Toxicon ◽

10.1016/j.toxicon.2012.07.137 ◽

2013 ◽

Vol 68 ◽

pp. 109-110

Author(s):

R. Dmochowski ◽

D. Ginsberg ◽

K. Ethans ◽

M. Brin ◽

W. Lam ◽

...

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Safety Study ◽

Phase 3

Download Full-text

1515 PHASE 3 EFFICACY AND SAFETY STUDY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY

The Journal of Urology ◽

10.1016/j.juro.2011.02.1494 ◽

2011 ◽

Vol 185 (4S) ◽

Cited By ~ 2

Author(s):

David Ginsberg ◽

Angelo Gousse ◽

Véronique Keppenne ◽

Karl-Dietrich Sievert ◽

Catherine Thompson ◽

...

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Safety Study ◽

Phase 3

Download Full-text

Efficacy and safety of onabotulinumtoxina 100 U for treatment of urinary incontinence due to neurogenic detrusor overactivity in noncatheterizing multiple sclerosis patients

Toxicon ◽

10.1016/j.toxicon.2016.11.059 ◽

2016 ◽

Vol 123 ◽

pp. S19

Author(s):

Francisco Cruz ◽

Pierre Denys ◽

Veronique Keppenne ◽

Alfred Kohan ◽

Benjamin Brucker ◽

...

Keyword(s):

Multiple Sclerosis ◽

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Multiple Sclerosis Patients

Download Full-text

647 Efficacy and safety of onabotulinumtoxinA 100U for treatment of urinary incontinence due to neurogenic detrusor overactivity in non-catheterising multiple sclerosis patients

European Urology Supplements ◽

10.1016/s1569-9056(16)60649-8 ◽

2016 ◽

Vol 15 (3) ◽

pp. e647 ◽

Cited By ~ 1

Author(s):

E. Chartier-Kastler ◽

P. Denys ◽

V. Keppenne ◽

B. Brucker ◽

B. Egerdie ◽

...

Keyword(s):

Multiple Sclerosis ◽

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Multiple Sclerosis Patients

Download Full-text

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double Blind, Placebo-Controlled Trial

Yearbook of Urology ◽

10.1016/j.yuro.2012.05.049 ◽

2012 ◽

Vol 2012 ◽

pp. 163-164

Author(s):

E.S. Rovner

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Controlled Trial ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

UP-03.171 Efficacy and Safety of Onabotulinumtoxin A in Patients with Neurogenic Detrusor Overactivity: Pooled Analysis from Two Phase 3 Trials

Urology ◽

10.1016/j.urology.2011.07.1260 ◽

2011 ◽

Vol 78 (3) ◽

pp. S401

Author(s):

K.D. Sievert ◽

F. Cruz ◽

S. Herschorn ◽

A. Gousse ◽

J. Heesakkers ◽

...

Keyword(s):

Detrusor Overactivity ◽

Pooled Analysis ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Phase 3 ◽

Two Phase ◽

Onabotulinumtoxin A

Download Full-text

Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies

Journal of Pediatric Urology ◽

10.1016/j.jpurol.2019.12.012 ◽

2020 ◽

Vol 16 (2) ◽

pp. 180.e1-180.e8 ◽

Cited By ~ 1

Author(s):

Israel Franco ◽

Piet Hoebeke ◽

Małgorzata Baka-Ostrowska ◽

David Bolong ◽

Leon N. Davies ◽

...

Keyword(s):

Detrusor Overactivity ◽

Pediatric Patients ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Open Label ◽

Phase 3 ◽

Two Phase ◽

Term Efficacy

Download Full-text

579 EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY

European Urology Supplements ◽

10.1016/s1569-9056(11)60569-1 ◽

2011 ◽

Vol 10 (2) ◽

pp. 190 ◽

Cited By ~ 4

Author(s):

F. Cruz ◽

S. Herschorn ◽

J. Heesakkers ◽

P. Aliotta ◽

C. Thompson ◽

...

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity

Download Full-text

1655 LONG-TERM EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY

The Journal of Urology ◽

10.1016/j.juro.2012.02.1487 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Michael Kennelly ◽

Roger Dmochowski ◽

Karen Ethans ◽

Gilles Karsenty ◽

Gary Lemack ◽

...

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Term Efficacy

Download Full-text

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

European Urology ◽

10.1016/j.eururo.2011.07.002 ◽

2011 ◽

Vol 60 (4) ◽

pp. 742-750 ◽

Cited By ~ 287

Author(s):

Francisco Cruz ◽

Sender Herschorn ◽

Philip Aliotta ◽

Mitchell Brin ◽

Catherine Thompson ◽

...

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Controlled Trial ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13393973.14762081 ◽

2011 ◽

Author(s):

Eric Rovner ◽

Ahmed El-Zawahry

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Controlled Trial ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Double Blind ◽

Double Blind Placebo

Download Full-text